FDA Okays VNS for Epilepsy in Children as Young as 4 Years FDA Okays VNS for Epilepsy in Children as Young as 4 Years
VNS therapy is indicated as an adjunctive therapy to reduce the frequency of seizures in children with partial-onset seizures refractory to antiepileptic medications.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Alert Source Type: news
More News: Brain | Children | Epilepsy | Health | Neurology | Neurosurgery | Vagus Nerve Stimulation Therapy